The finasteride prostate cancer prevention trial (PCPT) : What have we learned?MELLON, J. Kilian.European journal of cancer (1990). 2005, Vol 41, Num 13, pp 2016-2022, issn 0959-8049, 7 p.Article

Management dilemmas in bladder cancer : Radical TUR ± systemic chemotherapy in the treatment of muscle-invasive bladder cancerFENELEY, Mark R; MELLON, J. Kilian.Seminars in urologic oncology. 2000, Vol 18, Num 4, pp 300-307, issn 1081-0943Article

Tyrosine kinase inhibitors of the epidermal growth factor receptor as adjuncts to systemic chemotherapy for muscle-invasive bladder cancerMCHUGH, Lynsey A; GRIFFITHS, T. R; KRIAJEVSKA, Marina et al.Urology (Ridgewood, NJ). 2004, Vol 63, Num 4, pp 619-624, issn 0090-4295, 6 p.Article

Alteration in urinary matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio predicts recurrence in nonmuscle-invasive bladder cancersDURKAN, Garrett C; NUTT, Joyce E; MARSH, Colin et al.Clinical cancer research. 2003, Vol 9, Num 7, pp 2576-2582, issn 1078-0432, 7 p.Article

Comet assay measures of DNA damage are predictive of bladder cancer cell treatment sensitivity in vitro and outcome in vivoBOWMAN, Karen J; AL-MONEEF, Manar M; SUMMERTON, Duncan J et al.International journal of cancer (Print). 2014, Vol 134, Num 5, pp 1102-1111, issn 0020-7136, 10 p.Article

Expression of S100A4 protein is associated with metastasis and reduced survival in human bladder cancerDAVIES, Barry R; O'DONNELL, Marie; DURKAN, Garrett C et al.Journal of pathology. 2002, Vol 196, Num 3, pp 292-299, issn 0022-3417Article

Transfection of S100A4 produces metastatic variants of an orthotopic model of bladder cancerLEVETT, Diana; FLECKNELL, Paul A; RUDLAND, Philip S et al.The American journal of pathology. 2002, Vol 160, Num 2, pp 693-700, issn 0002-9440Article

Prognostic significance of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in voided urine samples from patients with transitional cell carcinoma of the bladderDURKAN, Garrett C; NUTT, Joyce E; RAJJAYABUN, Paul H et al.Clinical cancer research. 2001, Vol 7, Num 11, pp 3450-3456, issn 1078-0432Article

A nuclear form of the heparin-binding epidermal growth factor-like growth factor precursor is a feature of aggressive transitional cell carcinomaADAM, Rosalyn M; DANCIU, Theodora; MCLELLAN, Dawn L et al.Cancer research (Baltimore). 2003, Vol 63, Num 2, pp 484-490, issn 0008-5472, 7 p.Article

Improving and predicting radiosensitivity in muscle invasive bladder cancerCOLQUHOUN, Alexandra J; JONES, George D. D; MANAR AL MONEEF et al.The Journal of urology. 2003, Vol 169, Num 6, pp 1983-1992, issn 0022-5347, 10 p.Article